BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18571215)

  • 1. The usefulness of cyclic diamidines with different core-substituents as antitumor agents.
    Spychała J
    Bioorg Chem; 2008 Aug; 36(4):183-9. PubMed ID: 18571215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
    Stolić I; Mišković K; Piantanida I; Lončar MB; Glavaš-Obrovac L; Bajić M
    Eur J Med Chem; 2011 Feb; 46(2):743-55. PubMed ID: 21227551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
    Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
    Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
    Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
    Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
    Kock I; Heber D; Weide M; Wolschendorf U; Clement B
    J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
    Sławiński J; Brzozowski Z
    Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
    Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semisynthesis and in vitro anticancer activities of andrographolide analogues.
    Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J
    Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
    Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
    Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses of novel heterocycles as anticancer agents.
    Chauhan PM; Martins CJ; Horwell DC
    Bioorg Med Chem; 2005 May; 13(10):3513-8. PubMed ID: 15848764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a new series of 4-chloro-2-mercapto-5-methylbenzenesulfonamide derivatives with potential antitumor activity.
    Sławiński J
    Eur J Med Chem; 2004 Feb; 39(2):179-88. PubMed ID: 14987826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 1-(3',4',5'-trimethoxy) phenyl naphtho[2,1b]furan as a novel anticancer agent.
    Srivastava V; Negi AS; Kumar JK; Faridi U; Sisodia BS; Darokar MP; Luqman S; Khanuja SP
    Bioorg Med Chem Lett; 2006 Feb; 16(4):911-4. PubMed ID: 16297622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives.
    Kattimani PP; Kamble RR; Kariduraganavar MY; Dorababu A; Hunnur RK
    Eur J Med Chem; 2013 Apr; 62():232-40. PubMed ID: 23353755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
    Saczewski F; Bułakowska A
    Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
    Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
    Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cytostatic and cytotoxic anticancer effects of bisfunctional agents: A strategy for the design of DNA binding agents.
    Spychała J
    Cancer Lett; 2009 Aug; 281(2):203-12. PubMed ID: 19303699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
    Hu K; Yao X
    Planta Med; 2002 Apr; 68(4):297-301. PubMed ID: 11988850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.